Publications 1999
Below our publications are listed using several headings. Scientific publications relate to original research, often published internationally, but also in the Dutch language. Professional publications are in Dutch and relate to reviews and expressions of opinions.
A few publications have no links. Reprints can be requested by our secretary.
|
Scientific publications international
|
|
|---|---|
|
1
|
de Jong-van den Berg LTW, Feenstra N, Sorensen HT, Cornel MC. Euromap Group, Improvement of Drug Exposure Data in a Registration of Congenital Anomalies. Pilot-Study: Pharmacist and Mother as Sources for Drug Exposure Data during Pregnancy. Teratology 1999; 60:33-6 |
|
2
|
de Jong-van den Berg LTW, van der Zee AH, Schaafsma E, de Smit D, Anderson C, Cornel MC. Counselling women about periconceptional use of folic acid: the role of the community pharmacist can be improved. Int J Pharm Pract 1999; 7: 138-42 |
|
3
|
de Vries CS, Duggan CA, Tromp ThFJ, de Jong-van den Berg LTW. Changing Prescribing in the Light of Tolerability Concerns. Drug Safety 1999;21(3):152-60 |
|
4
|
de Vries CS, Tromp ThFJ, Blijleven W, de Jong-van den Berg LTW. Prescription data as a tool in pharmacotherapy audit (I) general considerations. Pharm World Sci 1999;21(2):80-4 |
|
5
|
de Vries CS, van den Berg, Timmer JW, Reicher A, Blijleven W, Tromp ThFJ, de Jong-van den Berg LTW. Prescription data as a tool in pharmacotherapy audit (II) general considerations. Pharm World Sci 1999;21(2):85-90 |
|
6
|
de Walle HEK, de Jong-van den Berg LTW, Cornel MC. Periconceptional folic acid intake in the northern Netherlands. The Lancet 1999;353:1187-87 |
|
7
|
de Walle HEK, van der Pal KM, de Jong-van den Berg LTW, Jeeninga W, Schouten JSAG, de Rover CM, Buitendijk SE, Cornel MC. Effect of mass media campaign to reduce socioeconomic differences in women’s awareness and behavior concerning use of folic acid: cross sectional study. BMJ 1999;319:291-2 |
|
8
|
de Walle HEK, Cornel MC, de Smit DJ, de Jong-van den Berg LTW. Preconceptional Use of Folic Acid Amongst Women of Advanced Maternal Age. Prenat. Diagn. 1999;19:996-7 |
|
9
|
Egberts ACG, Veenstra, M., de Jong-van den Berg LTW. Antidepressant drug choice for first users in two regions in the Netherlands. Pharmacy World Sci 1999;21(3):132-36 |
|
10
|
Fijn R, Brouwers JRBJ, de Jong-van den Berg LTW. Cross-sectoral pharmacotherapeutic coherence in the Netherlands, Int J Pharm Pract 1999;7:159-66 |
|
11
|
Fijn R, Brouwers JRBJ, Knaap RJ, de Jong-van den Berg LTW. Drug and therapeutics (D&T) committees in Dutch hospitals: a nation wide survey of sturcture, activities, and drug selection procedures. Br J Clin Pharmacol 1999;48:239-46 |
|
12
|
Fijn R, de Jong-van den Berg LTW, Brouwers JRBJ., Rational pharmacotherapy in The Netherlands: Formulary management in Dutch Hospitals. Pharm World Sci 1999;21(2):74-9 |
|
13
|
Fijn R, de Vries CS, Engels, S.A.G., Brouwers J.R.B.J., Blaey, C.J. de, De Jong-van den Berg LTW. The quality of Dutch hospital drug formularies: evaluation of technical features and organisational information. Pharm World Sci 1999;21(3):120-6 |
|
14
|
IJben G, van Mil JWF, Tromp ThFJ, de Jong-van den Berg LTW. Quantification of communication processes, is it possible? Pharm World Sci 1999;21(5):195-9 |
|
15
|
Janknegt R, Meijler WJ, Sleijfer DTh, Brouwers JRBJ. 5-HT3 receptor antogonists for cytostatic therapy-associated nausea and vomiting: drug selection by means of the soja method, Eur Hosp Pharm;5:S64-S74 |
|
16
|
Janknegt R, Pinckaers JWM, Rohof MHC, Ausems MEM, Arbouw MEL, van der Velden RW, Brouwers JRBJ. Double-blind comparative study of droperidol, granisetron and granisetron plus dexamethasone as prophylactic anti-emetic therapy in patients undergoing abdominal, gynaelogical, breast or otolaryngological surgery. Anaesthesia 1999;54:1059-68 |
|
17
|
Mobach MP, Van der Werf JJ, Tromp ThFJ. APOM-project: managing change to the customer in community pharmacy practice. Pharmacy World Sci 1999;21(5):205-9 |
|
18
|
Oleson C, Sorensen HT, de Jong-van den Berg LTW, Olsen J, Steffensen FH. The Euromap Group, Prescribing during pregnancy and lactation with reference to the Swedish classification system, Acta Obstet et Gynecol Scand 1999;78:686-92 |
|
19
|
Oleson C, Steffensen FH, Nielsen GL, de Jong-van den Berg LTW, Olsen J, Sørensen HT. The Euromap Group, Drug use in first pregnancy and lactation: a population-based survey among Danish women. Eur J Clin Pharmacol 1999;55:139-44 |
|
20
|
Postma MJ, Beck EJ, Mandalia S, Sherr L, Walters MD, Houweling H, Jager JC. Universal HIV screening of pregnant women in England: cost effectiveness analysis. BMJ 1999;318:1656-60 |
|
21
|
Postma MJ, Bos JM, van Gennep M, Jager JC, Baltussen R, Sprenger MJW. Economic Evaluation of Influenza Vaccination, Assesment for the Netherlands. Pharmacoeconomics 1999;16 Suppl1:33-40. |
|
22
|
Rutten-van Mölken MP, Postma MJ, Joore MA, Van Genugten ML, Leidl R, Jager JC. Current and future medical costs of asthma and chronic obstructive pulmonary disease in the Netherlands. Respiratory Medicine 1999;93(11):779-87 |
|
23
|
Timmer JW, de Smet AGM, Schuling J, Tromp ThFJ, de Jong-van den Berg LTW. Patient education to users of oral hypoglycemic agents: the perspective of dutch community pharmacists. Pharmacy World Sci 1999;21(5):200-4 |
|
24
|
Tromp ThFJ, Informe del Grupo de Trabajo para implementar la Atención Farmaceutica en el curriculum. Pharmaceutical Care España 1999;1:270-8 |
|
25
|
van Mil JWF, Tromp ThFJ, McElnay JC, de Jong-van den Berg LTW, Vos R. Development of Pharmaceutical Care in the Netherlands: Pharmacy’s Contemporary Focus on the Patient. J Am Pharm Assoc. 1999;39(3):395-401 |
|
26
|
Wieringa NF, de Graeff PA, van der Werf GT, Vos R. Cardiovascular drugs: discrepancies in demographics between pre- and post-registration use. Eur J Clin Pharmacol 1999;55:537-44 |
|
Scientific publications national
|
|
|
1
|
Brouwers JRBJ, Booy A, Koopmans A, Tel W, Voskuil J-H, Tytgat GNJ. Sedatie en bewaking bij gastrointestinale endoscopie. Pharmaceutisch Weekblad (ZF) 1999;134:518-24
|
|
2
|
Brouwers JRBJ, Booy A, Koopmans A, Tel W, Voskuil J-H, Tytgat GNJ. Sedatie en bewaking bij gastrointestinale endoscopie, MAGNA 1999 (tijdschrift maag-darmartsen Nederland);5(2):8
|
|
3
|
Brouwers JRBJ, Offringa M, Sanwikarja S, Westbroek J. Talk bij pleura-effusie: een wedergeboorte? Pharmaceutisch Weekblad 1999;134(24):821-7
|
|
4
|
de Koning JP, Tromp ThFJ, Lerk CF. Poederinhalatoren. Instructie voor gebruik. Medisch Contact 1999 april,10-4
|
|
5
|
Duchateau AMJA, van Loenen AC, Tijssen JPG, van der Kley BM, Harting JW, Brouwers JRBJ et al., Behandeling van ovariumcarcinoom: overtuigende resultaten van carboplatinemonotherapie. Pharmaceutisch Weekblad 1999;134(33):1155
|
|
6
|
Janknegt R, Arbouw MEL, van der Velden RW, Pinckaers J, Rohof MHC, Ausems MEM, Brouwers JRBJ. Profylaxe van postoperatieve misselijkheid en braken: kosten efectiviteit van de medicmenteuze behandeling. Pharmaceutisch Weekblad [ZF] 1999;134(50):1736-41.
|
|
7
|
Postma MJ, Welte R, van den Hoek JAR, van Doornum GJJ, Coutinho RA, Jager JC. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].Opportunistische screening op genitale infecties met Chlamydia trachomatis onder de seksueel actieve bevolking in Amsterdam. II. Ned Tijdschr Geneesk 1999;143(13):677-81
|
|
8
|
Postma MJ, Welte R, van der Hoek JAR, van Doornum GJJ, Coutinho RA, Jager JC. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment]. Opportunistische screening op genitale infecties met Chlamydia trachomatis onder de seksueel actieve bevolking in Amsterdam. III. Kosteneffectiviteitsanalyse van screening bij vrouwen uitgebreid met de rol van herinfectie en partnermeebehandeling. Ned Tijdschr Geneesk 1999;143:2383-5
|
|
9
|
Postma MJ, van der Hoek JAR. [Screening for Chlamydia trachomatis infection: which target group and at what price?]. Screening op infectie door Chlamydia trachomatis: welke doelgroep en tegen welke prijs? Ned Tijdschr Geneesk 1999:143:1237-8
|
|
10
|
Schaafsma E. Farmacie op zee. Pharmaceutisch Weekblad 1999;134:(43):1496
|
|
11
|
van der Kam WJ, Grotenhuis HG, Tromp ThFJ, Meyboom-de Jong B. De kwaliteit van medicatiegegevens rondom een opname. EMD 1999:37-44
|
|
Professional publications
|
|
|
1
|
Brouwers JRBJ. NHG-standaard ‘Osteoporose’ Een gedurfde keuze. Modern Medicine 1999;8:706-13
|
|
2
|
de Jong-van den Berg LTW, de Walle HEK. Foliumzuurgebruik onder vuur. Pharmaceutisch Weekblad 1999;134(41):1390
|
|
3
|
de Jong-van den Berg LTW. Wetenschap en praktijk in synergie, De werkvloer als laboratorium. Pharmaceutisch Weekblad 1999;134(5): 172-4
|
|
4
|
de Jong-van den Berg LTW. Kennis en gebruik van foliumzuur onder Nederlandse zwangeren. DES 1999;13(51):7-7
|
|
5
|
Jansman FGA, Coenen JLLM, Brouwers JRBJ. Geneesmiddelprofiel Raltitrexid (Tomudex R). Pharmaceutisch Weekblad 1999;134:488-93
|
|
6
|
Londeman JE, Ruskamp JW, de Jong-van den Berg LTW. Kwaliteitskring De Liemers communiceert digitaal. Pharmaceutisch Weekblad 1999;134(40):1382
|
|
7
|
van der Pal-de Bruin KM, de Walle HEK, Jeeninga W, de Rover CM, Cornel MC, de Jong-van den Berg LTW, Buitendijk SE. Foliumzuurgebruik door zwangere vrouwen in Nederland. Tijdschrift voor Verloskundigen 1999:324-8
|
|
8
|
van Roon ER, Brouwers JRBJ. NHG-standaard Cholesterol (1e herziening). Pharmaceutisch Weekblad 1999;134(48):1675-80.
|
|
Book (Chapter)
|
|
|
1
|
Brouwers JRBJ, Moolenaar F, Breedveld FC. Niet-opioide analgetica en antireumatica.Hfd. 18 in: Wesseling/Neef/de Graeff, Algemene Farmacotherapie: het geneesmiddel in theorie en praktijk (uitg. Bohn Stafleu van Loghum) Houten-Diegem 1999 p.277-307.
|
| Laatst gewijzigd: | 12 februari 2024 12:51 |